• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Involvement of lncR-30245 in Myocardial Infarction–Induced Cardiac Fibrosis Through Peroxisome Proliferator-Activated Receptor-γ–Mediated Connective Tissue Growth Factor Signalling Pathway
ConclusionOur study indicates that the lncR-30245/PPAR-γ/CTGF pathway mediates MI-induced cardiac fibrosis and might be a therapeutic target for various cardiac diseases associated with fibrosis.RésuméContexteLes longs ARN non codants (lncRNA) se révèlent actuellement comme des médiateurs importants de la physiopathologie cardiaque. Le but de la présente étude est d’examiner les effets d’un lncRNA (lncR-30245) sur la fibrogenèse cardiaque et les mécanismes sous-jacents.MéthodologieUn infarctus du myocarde (IM) et le facteur de croissance transformant β1 (TGF-β1) ont été utilisés pour produire des phéno...
Source: Canadian Journal of Cardiology - March 30, 2019 Category: Cardiology Source Type: research

Involvement of lncR-30245 in myocardial infarction-induced cardiac fibrosis through PPAR-γ-mediated CTGF signaling pathway
ConclusionOur study indicates that the lncR-30245/PPAR-γ/CTGF pathway mediates MI-induced cardiac fibrosis and might be a therapeutic target for various cardiac diseases associated with fibrosis.
Source: Canadian Journal of Cardiology - February 16, 2019 Category: Cardiology Source Type: research

Suppression of lncR-30245 alleviates myocardial infarction induced cardiac fibrosis via the PPAR- γ/CTGF pathway
Conclusion Our study indicates that the lncR-30245/PPAR-γ/CTGF pathway mediates MI-induced cardiac fibrosis and might be a therapeutic target for various cardiac diseases associated with fibrosis. Teaser LncR-30245, a conserved lncRNA promotes collagen production and cardiac fibroblast proliferation. Knockdown of lncR-30245 significantly inhibits TGF-β1-induced collagen production and cardiac fibroblast proliferation. Importantly, silencing of lncR-30245 significantly alleviates cardiac fibrosis and improves cardiac function after MI. The PPAR-γ/CTGF signaling pathway is involved in the regulation of cardiac fibrosis by...
Source: Canadian Journal of Cardiology - April 19, 2018 Category: Cardiology Source Type: research